Results 11 to 20 of about 1,242,031 (332)

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1

New England Journal of Medicine, 2020
Aerosol and Surface Stability of SARS-CoV-2 In this research letter, investigators report on the stability of SARS-CoV-2 and SARS-CoV-1 under experimental conditions.
N. van Doremalen, T. Bushmaker, Dylan H. Morris, M. Holbrook, Amandine Gamble, Brandi N. Williamson, A. Tamin, J. Harcourt, N. Thornburg, S. Gerber, J. Lloyd-Smith, E. de Wit, V. Munster   +12 more
semanticscholar   +1 more source

Massive dissemination of a SARS-CoV-2 Spike Y839 variant in Portugal [PDF]

, 2020
Funding This study is co-funded by Fundação para a Ciência e a Tecnologia and Agência de Investigação Clínica e Inovação Biomédica [grant number 234_596874175] on behalf of the Research 4 COVID-19 call. This work is also a result of the GenomePT project [
Portuguese network for SARS-CoV-2 genomics
core   +1 more source

Flexible upscaling of laboratory PCR testing capacity at the Robert Koch Institute during the SARS-CoV-2 pandemic

Virology Journal, 2023
Background Over the course of the COVID-19 pandemic, laboratories worldwide have been facing an unprecedented increase in demand for PCR testing because of the high importance of diagnostics for prevention and control of virus spread.
Eva Krause, Janine Michel, Andreas Puyskens, Natalie Hofmann, Thomas Rinner, Barbara Biere, Brigitte G. Dorner, Martin Skiba, Lars Schaade, Andreas Nitsche   +9 more
doaj   +1 more source

Using primary literature on SARS‐CoV‐2 to promote student learning about evolution [PDF]

Ecology and Evolution, 2020
AbstractThe ongoing COVID‐19 pandemic caused by SARS‐CoV‐2 has caused widespread deaths, illnesses, and societal disruption. I describe here how I pivoted a discussion‐based senior biology capstone course to include a multiweek module surrounding one primary literature paper on the evolution of SARS‐CoV‐2 and the subsequent scientific discourse about ...
openaire   +5 more sources

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

New England Journal of Medicine, 2020
Background Vaccines are needed to prevent coronavirus disease 2019 (Covid-19) and to protect persons who are at high risk for complications. The mRNA-1273 vaccine is a lipid nanoparticle–encapsulated mRNA-based vaccine that encodes the prefusion ...
L. Baden, Hana M. El Sahly, B. Essink, K. Kotloff, S. Frey, R. Novak, D. Diemert, S. Spector, N. Rouphael, C. Creech, J. Mcgettigan, Shishir Kehtan, N. Segall, Joel Solis, A. Brosz, C. Fierro, H. Schwartz, K. Neuzil, L. Corey, P. Gilbert, H. Janes, D. Follmann, M. Marovich, J. Mascola, L. Polakowski, J. Ledgerwood, B. Graham, H. Bennett, R. Pajon, C. Knightly, B. Leav, W. Deng, Honghong Zhou, Shu Han, M. Ivarsson, Jacqueline M. Miller, T. Zaks   +36 more
semanticscholar   +1 more source

Questions concerning the proximal origin of SARS‐CoV‐2

Journal of Medical Virology, 2020
مجلة علم الفيروسات الطبية المجلد 93، العدد 3 ص. 1204-1206 رسالة إلى EDITORأسئلة الوصول المفتوحة المتعلقة بالأصل القريب لسارس- كوف-2 مراد سيران، عدوى مراد سيران، الخباثة والمناعة الذاتية (NIIMA)، الشبكة العالمية للتعليم العلمي والبحوث (USERN)، دراسات الدكتوراه في العلوم الطبيعية والتقنية (SPL 44)XS، جامعة فيينا، فيينا، النمسا العدوى، الخباثة والمناعة ...
Tarek Mohamed Abd El-Aziz, Tarek Mohamed Abd El-Aziz, Murat Seyran, Amos Lal, Murtaza M. Tambuwala, Sk. Sarif Hassan, Pabitra Pal Choudhury, Gajendra Kumar Azad, Bruce D. Uhal, Samendra P. Sherchan, Antonio G. Soares, Damiano Pizzol, Kenneth Lundstrom, Ramesh Kandimalla, Alaa A. A. Aljabali, Adam Brufsky, Nima Rezaei, Nima Rezaei, Parise Adadi, Vladimir N. Uversky   +19 more
openaire   +5 more sources

Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.

Journal of the American Medical Association (JAMA), 2020
Importance In December 2019, a novel coronavirus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) emerged in China and has spread globally, creating a pandemic. Information about the clinical characteristics of infected patients who require
G. Grasselli, A. Zangrillo, A. Zanella, M. Antonelli, L. Cabrini, A. Castelli, D. Cereda, A. Coluccello, G. Foti, R. Fumagalli, G. Iotti, N. Latronico, L. Lorini, S. Merler, G. Natalini, A. Piatti, M. Ranieri, A. Scandroglio, E. Storti, M. Cecconi, A. Pesenti   +20 more
semanticscholar   +1 more source

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

Science, 2020
How SARS-CoV-2 binds to human cells Scientists are racing to learn the secrets of severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2), which is the cause of the pandemic disease COVID-19. The first step in viral entry is the binding of the viral
R. Yan, Yuanyuan Zhang, Yaning Li, L. Xia, Yingying Guo, Qiang Zhou   +5 more
semanticscholar   +1 more source

Genomic Sequencing and Analysis of a Novel Human Cowpox Virus With Mosaic Sequences From North America and Old World Orthopoxvirus

Frontiers in Microbiology, 2022
Orthopoxviruses (OPXVs) not only infect their natural hosts, but some OPXVs can also cause disease in humans. Previously, we partially characterized an OPXV isolated from an 18-year-old male living in Northern Norway.
Diana Diaz-Cánova, Ugo L. Moens, Annika Brinkmann, Andreas Nitsche, Malachy Ifeanyi Okeke   +4 more
doaj   +1 more source

The proximal origin of SARS-CoV-2

Nature Network Boston, 2020
SARS-CoV-2 is the seventh coronavirus known to infect humans; SARSCoV, MERS-CoV and SARS-CoV-2 can cause severe disease, whereas HKU1, NL63, OC43 and 229E are associated with mild symptoms6. Here we review what can be deduced about the origin of SARS-CoV-
K. Andersen, K. Andersen, A. Rambaut, W. Lipkin, E. Holmes, R. Garry   +5 more
semanticscholar   +1 more source